Anti-Nephrin Antibodies in Minimal Change Disease
Approach to the Patient with Peritoneal Dialysis Catheter Dysfunction- Part 1
Want to write a case report? RFN has you covered with a list of journals to choose from
Have a Nephrology Question? There Might Be A #Tweetorial For That!
Conferences, Courses, & Grants
FOAMed
Interventional Nephrology Series
Focus on Point-of-Care Ultrasound in Nephrology (POCUN) Series
Kidney Biopsy of the Month Series
Drug Trials
Last week’s poll results: who should provide funding for large, randomized controlled drug trials? Most respondents (58%) chose the diplomatic answer and said that it should be a combination between government and pharmaceutical companies. I was somewhat surprised…
The trials of a lab rat…
I was on the phone to one of my friends the other day. He’s a renal fellow currently doing lab-based research in Boston. He’s been having a difficult time of it lately, with none of his experiments working…
The actin cytoskeleton of the podocyte
Peter Mundel, a well-known researcher of podocyte biology, gave our Renal Grand Rounds today. Here’s what I took away from this morning’s talk: -regulation of the podocyte’s actin cytoskeleton is postulated to be the final common pathway in…
How Luminex Beads Work
You may have come across the phrase “Luminex beads” while doing your transplant nephrology rotation, or heard the term while hanging out in the Tissue Typing Lab. This post is intended to briefly describe the Luminex technology and…
Green Peritoneal Dialysis Fluid
This month’s Kidney International “Nephrology Image” features a report by Chen et al in which they describe a PD patient who noted cloudy, deep green dialysate fluid upon drainage of their peritoneum. They also presented with right upper…
AJKD Bundling Editorials
This month’s issue of AJKD includes an enlightening group of 6 editorials, each written from a unique perspective (e.g., the perspective of large dialysis corporations, the perspective of the ESRD Networks, the perspective of non-profit dialysis corporations, etc.),…
Rituximab in Refractory Lupus Nephritis
Linking up nicely with Nate’s rituximab post from this Tuesday, I wanted to mention a patient with lupus nephritis whom I saw in clinic this week. She had had horrendous renal disease, as seen on the three kidney…
A Divided Consensus on Health Care Reform
Interestingly, there was a near 50-50 divide on last week’s poll question regarding the surprising election of Republican Scott Brown to the U.S. Senate in the state of Massachusetts. Many viewed the election as a referendum on public…
Glomerular Density and Predicting Progression in IgA Nephropathy
IgA nephropathy (IgAN) is an unpredictable beast, and identifying patients who will go on to develop progressive disease can be challenging. The classic predictors of progression, namely heavy proteinuria, CKD, glomerular sclerosis and tubulointerstitial fibrosis, are themselves just…
Potential Use of Rituxan in Membranous Nephropathy
Take-home points from Mayo Clinic’s Fernando Fervenza’s excellent Renal Grand Rounds this morning, in which he addresses the potential use of rituximab as a treatment for membranous nephropathy: -the “rule of thirds” that we learn about membranous nephropathy (e.g.,…